Cinnamaldehyde Attenuates Atherosclerosis Via Targeting The I Kappa B/Nf-Kappa B Signaling Pathway In High Fat Diet-Induced Apoe(-/-) Mice

Weifeng Li,Wenbing Zhi,Jinmeng Zhao,Wenqi Li,Lulu Zang,Fang Liu,Xiaofeng Niu
DOI: https://doi.org/10.1039/c9fo00396g
IF: 6.3173
2019-01-01
Food & Function
Abstract:Cinnamaldehyde is a flavor isolated from the bark of Cinnamomum cassia Presl and exerts anti-inflammation effects in various diseases. In our study, we investigated the protective effects and the potential mechanism of cinnamaldehyde on atherosclerosis (AS) by using a high fat diet (HFD)-fed ApoE(-/-) atherosclerotic mouse model. Here, we found that the serum LDL-C, TG and TC levels were elevated and the HDL-C level was decreased in HFD-fed ApoE(-/-) mice. Cinnamaldehyde treatment significantly decreased inflammatory cytokine (TNF-alpha, IL-6, NO and MCP-1) overproduction and the serum lipid level. Meanwhile, cinnamaldehyde increased the HDL-C level and down-regulated the activity of lipid peroxidation product MDA in serum. Moreover, cinnamaldehyde reduced the atherosclerotic plaque area in ApoE(-/-) mice. Furthermore, cinnamaldehyde reduced matrix metalloproteinase-2 (MMP-2) expression and attenuated the high phosphorylation level of I kappa B alpha and p65 NF-kappa B. Overall, our study indicates that cinnamaldehyde may achieve the anti-atherosclerotic effect via the I kappa B/NF-kappa B signaling pathway.
What problem does this paper attempt to address?